Markus Jerling
Technik-/Wissenschafts-/F&E-Leiter bei ONCOZENGE AB
Ursprung des Netzwerks ersten Grades von Markus Jerling
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.
55
| Extinct | Pharmaceuticals: Major | 55 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases
20
| Extinct | Biotechnology | 20 |
13
| Public Company | Pharmaceuticals: Major | 13 |
| Public Company | Pharmaceuticals: Major | 12 | |
10
| Public Company | Pharmaceuticals: Major | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Markus Jerling
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Uppsala | College/University | Graduate Degree Masters Business Admin Undergraduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree Graduate Degree Doctorate Degree | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MONSANTO | Wholesale Distributors | Director/Board Member Director/Board Member Director of Finance/CFO Corporate Officer/Principal Public Communications Contact Chief Tech/Sci/R&D Officer Human Resources Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Sales & Marketing Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Human Resources Officer Compliance Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Michigan | College/University | Undergraduate Degree Masters Business Admin Graduate Degree Doctorate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Compliance Officer Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Founder General Counsel Corporate Officer/Principal | |
| KLARIA PHARMA HOLDING AB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chairman Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Public Communications Contact | |
| The University of Texas at Austin | College/University | Undergraduate Degree Doctorate Degree Corporate Officer/Principal | |
| University of Wisconsin | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact | |
| ASARINA PHARMA AB | Pharmaceuticals: Major | Chairman Founder Comptroller/Controller/Auditor | |
| PROCTER & GAMBLE COMPANY | Household/Personal Care | Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact | |
| Temple University (Pennsylvania) | College/University | Graduate Degree Masters Business Admin Undergraduate Degree | |
| University of Stockholm | College/University | Undergraduate Degree Director/Board Member Doctorate Degree | |
| University of Cape Town | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Royal Institute of Technology | College/University | Graduate Degree Doctorate Degree Graduate Degree | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director of Finance/CFO | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Doctorate Degree | |
| KARESSA PHARMA HOLDING AB (PUBL) | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| Blasieholmen Investment Group AB | Director/Board Member Director/Board Member | ||
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ZOETIS INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| Georgetown University | College/University | Undergraduate Degree Doctorate Degree | |
| ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
iNovacia AB
 iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Miscellaneous Commercial Services | Chief Executive Officer Founder | |
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel General Counsel | |
| NICOCCINO HOLDING AB | Tobacco | Director/Board Member Director of Finance/CFO | |
Karolinska Institutet Innovations AB
 Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Comptroller/Controller/Auditor | |
Karolinska University Hospital
 Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
| SALTX TECHNOLOGY HOLDING AB | Electronic Production Equipment | Chairman Chief Executive Officer | |
| University of Lund | College/University | Graduate Degree Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 30 |
| Schweden | 19 |
| Kanada | 2 |
| Südafrika | 2 |
Sektoral
| Health Technology | 23 |
| Consumer Services | 14 |
| Finance | 4 |
| Commercial Services | 4 |
| Consumer Non-Durables | 3 |
Operativ
| Director/Board Member | 538 |
| Corporate Officer/Principal | 256 |
| Independent Dir/Board Member | 149 |
| Chairman | 116 |
| Chief Executive Officer | 84 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Erik Kjellsson Nerpin | 79 |
| Carola Elisabet Lemne | 49 |
| Kenneth Lee | 40 |
| Ed Borkowski | 32 |
| Donald Parfet | 31 |
| Michael Friedman | 30 |
| Mark Corrigan | 29 |
| Santo Costa | 28 |
| Paul Edick | 27 |
| Ismail Kola | 26 |
| Charles Rowland | 25 |
| Michael Owens | 25 |
| Francesco Granata | 24 |
| Timothy Rothwell | 24 |
| Hans-Peder Richter | 24 |
- Börse
- Insiders
- Markus Jerling
- Unternehmensverbindungen
